News

Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective

Unilife Medical Solutions has filed patent applications in the US for a new ready-to-fill syringe product to be marketed as the Unifill Select. The Unifill Select is a

Gen-Probe’s subsidiary, Prodesse has received FDA clearence for marketing its ProParaflu+ assay in the US. Its a molecular test that detects and differentiates parainfluenza 1, 2 and 3

American Health Packaging has launched additional SKUs in unit-dose line. The SKU’s includes: Ethambutol HCl tablet 400-mg tablets (AB-rated to Myambutol), Rifampin 150mg and 300mg tablets (AB-rated to

QLT has announced the settlement of its litigation with the General Hospital, doing business as Massachusetts General Hospital (MGH). Under the terms of the settlement agreement, QLT will

Nanosphere has received 510(k) clearance from the FDA to update its package insert for its Verigene Respiratory Virus Nucleic Acid Test on Verigene SP System (RVNATSP). It is

Catalent Pharma Solutions (Catalent) has appointed Paul Burns as a new vice president of global sales. In this newly created role, Mr. Burns will be responsible for developing

American Scientific Resources (ASR) has opened a regional marketing and production management office in Shanghai, China. The company has been able to secure a location abroad, providing an

LFB Biotechnologies’ (LFB) recombinant anti-CD20 monoclonal antibody received orphan drug status for the treatment of chronic lymphocytic leukemia (CLL). The company received the approval from the EMEA’s Committee